Fiduciary Family Office’s Boston Scientific BSX Stock Holding History

Fiduciary Family Office’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.49M	Buy	34,870 +12,334	+55%	+$670K	0.37%	50
2026 Q1	$1.41M	Buy	22,536 +12,875	+133%	+$1.03M	0.4%	50
2025 Q4	$921K	Sell	9,661 -126	-1%	-$12.4K	0.26%	68
2025 Q3	$956K	Sell	9,787 -3,699	-27%	-$383K	0.27%	74
2025 Q2	$1.45M	Sell	13,486 -750	-5%	-$75.9K	0.47%	41
2025 Q1	$1.44M	Buy	+14,236	New	+$1.43M	0.48%	40
2024 Q4	–	Sell	-11,956	Closed	-$1M	–	104
2024 Q3	$1M	Sell	11,956 -1,186	-9%	-$93.5K	0.33%	65
2024 Q2	$1.01M	Sell	13,142 -1,370	-9%	-$100K	0.4%	64
2024 Q1	$994K	Buy	14,512 +4,359	+43%	+$280K	0.39%	68
2023 Q4	$587K	Buy	+10,153	New	+$542K	0.26%	96

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fiduciary Family Office's BSX Position: Q2 2026 in Review

Fiduciary Family Office increased its Boston Scientific (BSX) stake by 55% in Q2 2026, buying an estimated $670K and bringing the position to 34,870 shares worth $1.49M. The position accounts for 0.37% of the portfolio, ranked #50.

Fiduciary Family Office first reported a position in BSX in Q4 2023 and has held it in 10 quarters since. 1,478 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Fiduciary Family Office held 34,870 shares of Boston Scientific worth $1.49M as of Q2 2026.
Fiduciary Family Office bought 12,334 Boston Scientific shares in Q2 2026, an estimated $670K.
Boston Scientific made up 0.37% of Fiduciary Family Office's portfolio in Q2 2026, its #50 holding.
Fiduciary Family Office first reported a position in Boston Scientific in Q4 2023 and has held it in 10 quarters since.
1,478 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Fiduciary Family Office's 13F filing for Q2 2026, filed 5 Aug 2026.